Who
James Jones
Director
Company insider
Files Form 4 as: Director, Cumberland Pharmaceuticals.
In numbers
- Trades disclosed
- 760
- Buys
- 472
- Sells
- 0
- Bought
- $59K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 May 2010
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $5,0401,800 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $5,0401,800 at $2.80 | filing |
| 31 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $277 at $3.91 | filing |
| 31 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $277 at $3.91 | filing |
| 30 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $3.94 | filing |
| 30 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $3.94 | filing |
| 29 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $4.01 | filing |
| 29 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $328 at $4.01 | filing |
| 26 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.21 | filing |
| 26 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.21 | filing |
| 24 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.26 | filing |
| 24 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.26 | filing |
| 23 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $338 at $4.13 | filing |
| 23 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $338 at $4.13 | filing |
| 22 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $307 at $4.32 | filing |
| 22 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $307 at $4.32 | filing |
| 19 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.19 | filing |
| 19 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $348 at $4.19 | filing |
| 18 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $4210 at $4.19 | filing |
| 18 Dec 2025filed 6 Jan 2026 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code L | $4210 at $4.19 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Head to Head Review: Cumberland Pharmaceuticals (NASDAQ:CPIX) & Eloxx Pharmaceuticals (NASDAQ:ELOX)CPIX · dailypolitical.com · 17 Oct 2026Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Cumberland Pharmaceuticals (NASDAQ:CPIX)CPIX · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name James Jones; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.